Study illustrates the dynamics of tumor evolution in cancers, suggesting novel therapeutic pathways.
The stubborn proliferation and recurrence of tu- mors represent one of the most critical challenges in contemporary biomedicine. Traditional linear or exponential growth models often fail to explain the non-linear mutational outbursts and ”cannon-ball” multi-organ metastases observed following clini- cal interventions. This paper proposes a novel paradigm in systems biology by mapping the Col- latz Conjecture (3n + 1) from number theory onto the non-asymmetric evolutionary pathways of tu- mor cells. Genomic instability is defined as the asymmetric ”odd term n,” where the 3n + 1 oper- ation corresponds to the compensatory clonal out- bursts and immune evasion noise (+1) triggered by mutant clones seeking topological equilibrium. Concurrently, clinical regimens act as the symmet- ric cleavage of even terms (÷2). By validating this model through the dynamics of three distinct clinical cases—Small Cell Lung Cancer (SCLC), Triple-Negative Breast Cancer (TNBC), and Glioblastoma (GBM)—we demon- strate that conventional non-specific elimination (÷2) based purely on tumor volume inevitably forces the system to converge into the ”4-2-1 topo- logical attractor” lock. Finally, we explore a new feasible pathway for implementing topologi- cal blockade via Zinc Oxide Quantum Dots (ZnO QDs) microenvironmental gated technology paired with localized computational interventions.
No takes yet. Share an insight, caveat, or question.
C Y Lin (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: